Trinity Biotech
TRIB
22 hedge funds and large institutions have $9.66M invested in Trinity Biotech in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
7.87% less ownership
Funds ownership: 49.87% → 42% (-7.9%)
10% less capital invested
Capital invested by funds: $10.8M → $9.66M (-$1.1M)
12% less funds holding
Funds holding: 25 → 22 (-3)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$237K |
| 2 |
Renaissance Technologies
New York
|
+$196K |
| 3 |
HAIM
Hunter Associates Investment Management
Pittsburgh,
Pennsylvania
|
+$83.2K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$13.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$11.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FM
Fondren Management
Houston,
Texas
|
-$742K |
| 2 |
FWSM
First Wilshire Securities Management
Pasadena,
California
|
-$547K |
| 3 |
Morgan Stanley
New York
|
-$421K |
| 4 |
ARM
Adirondack Research & Management
Guilderland,
New York
|
-$365K |
| 5 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
-$115K |
TRIB Hedge Fund Activity: Q1 2020 in Review
22 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q1 2020, worth a combined $9.66M — down 10% from $10.8M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of TRIB and 1 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 4 added.
The largest buyer was Heartland Advisors, adding an estimated $237K. The largest seller was Fondren Management, cutting an estimated $742K.
- 22 institutional investors held Trinity Biotech (TRIB) as of Q1 2020, down from 25 in Q4 2019.
- Funds reported $9.66M of Trinity Biotech stock for Q1 2020, down 10% quarter-over-quarter.
- 1 fund opened new Trinity Biotech positions in Q1 2020 and 4 closed out, a net change of -3 holders.
- The largest Trinity Biotech buyer in Q1 2020 was Heartland Advisors, an estimated $237K added.
- The largest Trinity Biotech seller in Q1 2020 was Fondren Management, an estimated $742K sold.
Based on aggregated 13F filings for Q1 2020.